HRT Financial’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.7M Buy
+33,959
New +$3.31M ﹤0.01% 1676
2026
Q1
– Sell
-22,607
Closed -$389K – 3707
2025
Q4
$389K Buy
+22,607
New +$438K ﹤0.01% 2241
2024
Q2
– Sell
-20,250
Closed -$3.09M – 2146
2024
Q1
$3.09M Buy
+20,250
New +$3.37M 0.02% 409
2023
Q4
– Sell
-5,388
Closed -$2.39M – 2252
2023
Q3
$2.39M Buy
+5,388
New +$2.43M 0.02% 542
2023
Q2
– Sell
-37,986
Closed -$22.6M – 2387
2023
Q1
$22.6M Buy
+37,986
New +$21.3M 0.28% 54

Other funds holding AGL

HRT Financial's AGL Position: Q3 2026 in Review

HRT Financial opened a new position in Agilon Health (AGL) in Q3 2026: 33,959 shares worth $2.7M. The stake represents ﹤0.01% of the portfolio and ranks #1676 among its holdings. This is a return to the name: HRT Financial previously reported a position in AGL as recently as Q4 2025.

HRT Financial first reported a position in AGL in Q1 2023 and has held it in 5 quarters since. The position peaked at $22.6M in Q1 2023. 133 funds tracked by Wall St. Rank hold AGL as of Q3 2026.

  • HRT Financial held 33,959 shares of Agilon Health worth $2.7M as of Q3 2026.
  • Agilon Health was a new HRT Financial position in Q3 2026.
  • Agilon Health made up ﹤0.01% of HRT Financial's portfolio in Q3 2026, its #1676 holding.
  • HRT Financial first reported a position in Agilon Health in Q1 2023 and has held it in 5 quarters since.
  • HRT Financial's Agilon Health position peaked at $22.6M in Q1 2023.
  • 133 funds tracked by Wall St. Rank held Agilon Health as of Q3 2026.

Based on HRT Financial's 13F filing for Q3 2026, filed 13 Nov 2026.